Abstract |
Autosomal-dominant, Dutch-type cerebral amyloid angiopathy (D-CAA) offers a unique opportunity to develop biomarkers for pre-symptomatic cerebral amyloid angiopathy (CAA). We hypothesized that neuroimaging measures of white matter injury would be present and progressive in D-CAA prior to hemorrhagic lesions or symptomatic hemorrhage. In a longitudinal cohort of D-CAA carriers and non-carriers, we observed divergence of white matter injury measures between D-CAA carriers and non-carriers prior to the appearance of cerebral microbleeds and >14 years before the average age of first symptomatic hemorrhage. These results indicate that white matter disruption measures may be valuable cross-sectional and longitudinal biomarkers of D-CAA progression. ANN NEUROL 2022;92:358-363.
|
Authors | Zahra Shirzadi, Wai-Ying W Yau, Stephanie A Schultz, Aaron P Schultz, Matthew R Scott, Maged Goubran, Parisa Mojiri-Forooshani, Nelly Joseph-Mathurin, Kejal Kantarci, Greg Preboske, Marieke J H Wermer, Clifford Jack, Tammie Benzinger, Kevin Taddei, Hamid R Sohrabi, Reisa A Sperling, Keith A Johnson, Randall J Bateman, Ralph N Martins, Steven M Greenberg, Jasmeer P Chhatwal, DIAN Investigators |
Journal | Annals of neurology
(Ann Neurol)
Vol. 92
Issue 3
Pg. 358-363
(09 2022)
ISSN: 1531-8249 [Electronic] United States |
PMID | 35670654
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 American Neurological Association. |
Topics |
- Cerebral Amyloid Angiopathy
(diagnostic imaging, pathology)
- Cerebral Hemorrhage
(diagnostic imaging, pathology)
- Cross-Sectional Studies
- Hemorrhage
(pathology)
- Humans
- Magnetic Resonance Imaging
- Neuroimaging
- White Matter
(diagnostic imaging, pathology)
|